- Home
- CCK vs ASND Comparison
CCK vs ASND Comparison
Compare CCK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCK
- ASND
- Stock Information
- Founded
- CCK 1906
- ASND 2006
- Country
- CCK United States
- ASND Denmark
- Employees
- CCK N/A
- ASND N/A
- Industry
- CCK Containers/Packaging
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CCK Industrials
- ASND Health Care
- Exchange
- CCK Nasdaq
- ASND Nasdaq
- Market Cap
- CCK 12.1B
- ASND 10.6B
- IPO Year
- CCK N/A
- ASND 2015
- Fundamental
- Price
- CCK $100.53
- ASND $198.32
- Analyst Decision
- CCK Buy
- ASND Strong Buy
- Analyst Count
- CCK 13
- ASND 16
- Target Price
- CCK $121.23
- ASND $239.50
- AVG Volume (30 Days)
- CCK 1.4M
- ASND 549.0K
- Earning Date
- CCK 10-16-2025
- ASND 08-07-2025
- Dividend Yield
- CCK 1.03%
- ASND N/A
- EPS Growth
- CCK 31.02
- ASND N/A
- EPS
- CCK 4.73
- ASND N/A
- Revenue
- CCK $12,013,000,000.00
- ASND $576,332,355.00
- Revenue This Year
- CCK $3.91
- ASND $79.35
- Revenue Next Year
- CCK $2.67
- ASND $76.18
- P/E Ratio
- CCK $21.26
- ASND N/A
- Revenue Growth
- CCK 2.23
- ASND 54.50
- 52 Week Low
- CCK $75.98
- ASND $111.09
- 52 Week High
- CCK $109.48
- ASND $199.99
- Technical
- Relative Strength Index (RSI)
- CCK 44.39
- ASND 69.11
- Support Level
- CCK $100.01
- ASND $187.24
- Resistance Level
- CCK $102.92
- ASND $197.67
- Average True Range (ATR)
- CCK 1.65
- ASND 8.86
- MACD
- CCK 0.12
- ASND 1.92
- Stochastic Oscillator
- CCK 56.70
- ASND 95.73
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.